Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Yu-hsin Lin is Chief Executive Officer at Belite Bio. OQRO lists 28 transactions filed with the SEC under this name, the latest on Oct 31, 2026, each linked to the official Form 4.
Chief Executive Officer
Disclosures on record
28
Companies involved
1
Belite BioBLTE
28 disclosures · Apr 2026 – Oct 2026 · 25 sold
Oct 29, 20265,000disclosed Oct 31
DetailsOfficial recordSep 4, 2026Sold~$2.12Mdisclosed Sep 10
DetailsOfficial recordSep 8, 2026Sold~$1.73Mdisclosed Sep 10
DetailsOfficial recordSep 4, 2026Sold~$1.7Mdisclosed Sep 10
DetailsOfficial recordSep 4, 2026Sold~$1.57Mdisclosed Sep 10
DetailsOfficial recordSep 4, 2026Sold~$1.45Mdisclosed Sep 10
DetailsOfficial recordSep 8, 2026Sold~$1.19Mdisclosed Sep 10
DetailsOfficial recordSep 8, 2026Sold~$1.19Mdisclosed Sep 10
DetailsOfficial recordSep 4, 2026Sold~$1.15Mdisclosed Sep 10
DetailsOfficial recordSep 4, 2026Sold~$1.16Mdisclosed Sep 10
DetailsOfficial recordSep 4, 2026Sold~$908Kdisclosed Sep 10
DetailsOfficial recordSep 4, 2026Sold~$851Kdisclosed Sep 10
DetailsOfficial recordSep 4, 2026Sold~$810Kdisclosed Sep 10
DetailsOfficial recordSep 4, 2026Sold~$623Kdisclosed Sep 10
DetailsOfficial recordSep 4, 2026Sold~$573Kdisclosed Sep 10
DetailsOfficial recordSep 8, 2026Sold~$535Kdisclosed Sep 10
DetailsOfficial recordSep 8, 2026Sold~$466Kdisclosed Sep 10
DetailsOfficial recordSep 4, 2026Sold~$469Kdisclosed Sep 10
DetailsOfficial recordSep 4, 2026Sold~$475Kdisclosed Sep 10
DetailsOfficial recordSep 4, 2026Sold~$114Kdisclosed Sep 10
DetailsOfficial recordAug 12, 2026Sold~$40Kdisclosed Aug 14
DetailsOfficial recordAug 12, 2026Sold~$26Kdisclosed Aug 14
DetailsOfficial recordApr 21, 202610Kdisclosed Apr 24
DetailsOfficial recordApr 9, 2026Sold~$635Kdisclosed Apr 14
DetailsOfficial recordApr 9, 2026Sold~$547Kdisclosed Apr 14
DetailsOfficial recordApr 9, 2026Sold~$451Kdisclosed Apr 14
DetailsOfficial recordApr 9, 2026Sold~$37Kdisclosed Apr 14
DetailsOfficial recordMar 31, 2026207Kdisclosed Apr 3
DetailsOfficial recordAs of the latest filing on , Yu-hsin Lin reported holding 187,949 shares of Belite Bio (BLTE), worth about $30.9M at the last close of $164 (Nov 13, 2026). In the last 12 months, Yu-hsin Lin sold $20.8M in 25 sales.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Belite Bio BLTE | 187,949 | 188K direct | $164 | $30.9M | Oct 29, 2026 |
Is this Yu-hsin Lin’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Yu-hsin Lin has no open-market purchase on record since 2026. Sales in 1 of the 1 years since 2026.
Yu-hsin Lin reported 0 open-market purchases and 25 sales since 2026; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $20.8M25×25 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Oct 29, 2026, Yu-hsin Lin reported holding 187,949 shares of Belite Bio (BLTE). At the last close of $164 on Nov 13, 2026, that is about $30.9M. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Yu-hsin Lin reported 25 open-market sales worth $20.8M, and no open-market purchase. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Yu-hsin Lin has no open-market purchase on record since 2026. Sales in 1 of the 1 years since 2026.
In SEC filings since 2026: no open-market purchase is on record; the latest open-market sale is from 2026.
Belite Bio (BLTE), from 2026 to 2026: 0 purchases and 25 sales.
Yu-hsin Lin reported 0 open-market purchases and 25 sales here, 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.